Literature DB >> 15539495

Antigenic diversity and immune evasion by malaria parasites.

Marcelo U Ferreira1, Mônica da Silva Nunes, Gerhard Wunderlich.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15539495      PMCID： PMC524792          DOI： 10.1128/CDLI.11.6.987-995.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  119 in total

Review 1.  The origin of antigenic diversity in Plasmodium falciparum.

Authors:  S M Rich; M U Ferreira; F J Ayala
Journal:  Parasitol Today       Date:  2000-09

2.  High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations.

Authors:  Fabiana P Alves; Rui R Durlacher; Maria J Menezes; Henrique Krieger; Luiz H Pereira Silva; Erney P Camargo
Journal:  Am J Trop Med Hyg       Date:  2002-06       Impact factor: 2.345

3.  Association of malaria parasite population structure, HLA, and immunological antagonism.

Authors:  S C Gilbert; M Plebanski; S Gupta; J Morris; M Cox; M Aidoo; D Kwiatkowski; B M Greenwood; H C Whittle; A V Hill
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

4.  Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria.

Authors:  R F Anders
Journal:  Parasite Immunol       Date:  1986-11       Impact factor: 2.280

5.  Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria.

Authors:  F al-Yaman; B Genton; R Anders; J Taraika; M Ginny; S Mellor; M P Alpers
Journal:  Parasite Immunol       Date:  1995-09       Impact factor: 2.280

6.  Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.

Authors:  R Rosenberg; R A Wirtz; D E Lanar; J Sattabongkot; T Hall; A P Waters; C Prasittisuk
Journal:  Science       Date:  1989-09-01       Impact factor: 47.728

7.  Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1.

Authors:  Anna M Vogt; Antonio Barragan; Qijun Chen; Fred Kironde; Dorothe Spillmann; Mats Wahlgren
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

8.  Meiotic recombination, cross-reactivity, and persistence in Plasmodium falciparum.

Authors:  F E McKenzie; M U Ferreira; J K Baird; G Snounou; W H Bossert
Journal:  Evolution       Date:  2001-07       Impact factor: 3.694

9.  Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka.

Authors:  A C Gamage-Mendis; J Rajakaruna; R Carter; K N Mendis
Journal:  Am J Trop Med Hyg       Date:  1991-10       Impact factor: 2.345

10.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728
View more
  52 in total

1.  Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia.

Authors:  Kézia K G Scopel; Cor J F Fontes; Marcelo U Ferreira; Erika M Braga
Journal:  Clin Vaccine Immunol       Date:  2006-07

2.  Genetic diversity in merozoite surface protein (MSP)-1 and MSP-2 genes of Plasmodium falciparum in a major endemic region of Iran.

Authors:  Aliehsan Heidari; Hossein Keshavarz; Mohammad B Rokni; Tomas Jelinek
Journal:  Korean J Parasitol       Date:  2007-03       Impact factor: 1.341

3.  Low-complexity regions in Plasmodium falciparum: missing links in the evolution of an extreme genome.

Authors:  Martine M Zilversmit; Sarah K Volkman; Mark A DePristo; Dyann F Wirth; Philip Awadalla; Daniel L Hartl
Journal:  Mol Biol Evol       Date:  2010-04-28       Impact factor: 16.240

4.  Influence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian Women.

Authors:  Anna Babakhanyan; Yeung L Tutterrow; Naveen Bobbili; Ali Salanti; Andrew Wey; Josephine Fogako; Robert J Leke; Rose G F Leke; Diane Wallace Taylor
Journal:  Am J Trop Med Hyg       Date:  2015-12-28       Impact factor: 2.345

5.  BEI Resources: a biological resource center for parasitologists.

Authors:  Robert E Molestina
Journal:  Trends Parasitol       Date:  2010-12

6.  Stage independent chloroquine resistance and chloroquine toxicity revealed via spinning disk confocal microscopy.

Authors:  Bojana Gligorijevic; Kyle Purdy; David A Elliott; Roland A Cooper; Paul D Roepe
Journal:  Mol Biochem Parasitol       Date:  2008-01-09       Impact factor: 1.759

7.  Transcriptome analysis of the Cryptocaryon irritans tomont stage identifies potential genes for the detection and control of cryptocaryonosis.

Authors:  Yogeswaran Lokanathan; Adura Mohd-Adnan; Kiew-Lian Wan; Sheila Nathan
Journal:  BMC Genomics       Date:  2010-01-29       Impact factor: 3.969

8.  STEVOR is a Plasmodium falciparum erythrocyte binding protein that mediates merozoite invasion and rosetting.

Authors:  Makhtar Niang; Amy Kristine Bei; Kripa Gopal Madnani; Shaaretha Pelly; Selasi Dankwa; Usheer Kanjee; Karthigayan Gunalan; Anburaj Amaladoss; Kim Pin Yeo; Ndeye Sakha Bob; Benoit Malleret; Manoj Theodore Duraisingh; Peter Rainer Preiser
Journal:  Cell Host Microbe       Date:  2014-07-09       Impact factor: 21.023

9.  Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians.

Authors:  Melissa S Bastos; Mônica da Silva-Nunes; Rosely S Malafronte; Erika Hellena E Hoffmann; Gerhard Wunderlich; Sandra L Moraes; Marcelo U Ferreira
Journal:  Clin Vaccine Immunol       Date:  2007-08-15

10.  Multiple var2csa-type PfEMP1 genes located at different chromosomal loci occur in many Plasmodium falciparum isolates.

Authors:  Adam F Sander; Ali Salanti; Thomas Lavstsen; Morten A Nielsen; Pamela Magistrado; John Lusingu; Nicaise Tuikue Ndam; David E Arnot
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.